Autologous platelet-rich fibrin (PRF) augmentation as an add-on therapy in deep surgical site infections (dSSIs) after instrumented spinal surgery: preliminary results of a single institution case series - Poll - MDSpire

Autologous platelet-rich fibrin (PRF) augmentation as an add-on therapy in deep surgical site infections (dSSIs) after instrumented spinal surgery: preliminary results of a single institution case series

  • By

  • Ioannis Vasilikos

  • Roland Roelz

  • Christoph Scholz

  • Boris Mizaikoff

  • Katerina Argiti

  • Watzlawick Ralf

  • Georgios-Christos Giagkos

  • Evangelos M. Fragkakis

  • Shahram Ghanaati

  • Jürgen Beck

  • Ulrich Hubbe

  • August 24, 2021

  • 0 min

Share

Original Source(s)

Autologous platelet-rich fibrin (PRF) augmentation as an add-on therapy in deep surgical site infections (dSSIs) after instrumented spinal surgery: preliminary results of a single institution case series

  • by Ioannis Vasilikos, Roland Roelz, Christoph Scholz, Boris Mizaikoff, Katerina Argiti, Watzlawick Ralf, Georgios-Christos Giagkos, Evangelos M. Fragkakis, Shahram Ghanaati, Jürgen Beck, Ulrich Hubbe

  • August 24, 2021

Related Content

Layered precision suturing vs. traditional double-layer closure at cesarean: a randomized trial of uterine scar healing and maternal outcomes

Decellularized dermis allograft for the treatment of venous leg ulceration: the DAVE RCT

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.